Agency Links:    Home   Contact Us    Compliments & Complaints   Help    Site Map
Link to Homepage

Patient/Public Info  |  Regional Services  |  Health Professionals Info  |  About BCCA  |  Research  |  Donating

Lymphoma & Myeloma

The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer Agency's terms of use, available at www.bccancer.bc.ca/legal.htm.

Please note: See Leukemia/ BMT for Bone Marrow Transplant protocols. All links in the table below open PDF documents.

PROTOCOL CODE and DESCRIPTION AVAILABLE DOCUMENTS
(revision date indicated in red)
HLHETCSPA: Treatment of Hemophagocytic Lymphohistiocytosis with Etoposide, Dexamethasone and cycloSPORINE Protocol (01 Jul 2014)
Preprinted order wk 1-2 (01 Jul 2014)
Preprinted order wk 3-8 (01 Jul 2014)
LYABVD: Treatment of Hodgkin's disease with DOXOrubicin, Bleomycin, vinBLAStine and Dacarbazine Protocol (01 Jun 2014)
Preprinted order (01 Jun 2014)
Patient Handout (01 Jun 2013)
LYALEM: Treatment with Subcutaneous or Intravenous Alemtuzumab for Fludarabine-Refractory B-Chronic Lymphocytic Leukemia (B-CLL) or with Intravenous Alemtuzumab for Previously Untreated T-Prolymphocytic Leukemia (T-PLL) - Protocol (01 Jun 2014)
- Preprinted order (01 May 2014)
ULYBEND: Treatment of Non-Hodgkin Lymphoma with Bendamustine Protocol (01 Jun 2014)
Preprinted order (01 May 2014)
ULYBENDR: Treatment of Non-Hodgkin Lymphoma with Bendamustine and riTUXimab Protocol (01 Jun 2014)
Preprinted order (01 May 2014)
ULYBRENTUX: Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma with Brentuximab Protocol (01 Jun 2014)
Preprinted order (01 Jun 2014)
LYCARTOP: Summary for Topical Carmustine in Cutaneous T-cell Lymphoma Protocol (01 Jun 2010)
Preprinted order (01 Jul 2010)
Patient Handout (01 Aug 2010)
LYCCOP: Treatment of Hodgkin's disease using Cyclophosphamide, vinCRIStine, predniSONE - Protocol (01 Jun 2014)
LYCDA: Treatment of Hairy Cell Leukemia with Cladribine - Protocol (01 Jun 2014)
- Preprinted order (27 Jun 2011)
LYCHLOR: Therapy for Low Grade Lymphoma and Chronic Lymphocytic Leukemia Using Chlorambucil - Protocol (01 Jun 2014)
- Preprinted order (01 May 2009)
LYCHOP: Treatment of Lymphoma with DOXOrubicin, Cyclophosphamide, vinCRIStine and predniSONE - Protocol (01 Jun 2014)
- Preprinted order (01 Jun 2014)
LYCHOPR: Treatment of Lymphoma with DOXOrubicin, Cyclophosphamide, vinCRIStine, predniSONEand riTUXimab - Protocol (01 Jun 2014)
- Preprinted order (01 May 2014)
- Patient Handout (01 Feb 2012)
LYCHOPRMTX: Central Nervous System Prophylaxis with High Dose Methotrexate, CHOP and RiTUXimab in Diffuse Large B-cell Lymphoma Protocol (01 Jun 2014)
Preprinted order (01 Jun 2014)
ULYCLLBEND: Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL) with Bendamustine Protocol (01 Jun 2014)
Preprinted order (01 May 2014)
LYCODOXMR: Treatment of Burkitt’s Lymphoma and Leukemia (ALL-L3) with Cyclophosphamide, vinCRIStine, DOXOrubicin, Methotrexate, Leucovorin (CODOX-M) and riTUXimab - Protocol (01 Jun 2014)
- Preprinted order (01 Feb 2014)
LYCSPA: Cyclosporine for cytopenias associated with lymphoproliferative disorder of large granular lymphocytes - Protocol (01 Jun 2014)
- Preprinted order (01 Mar 2013)
LYCVP: Treatment of Advanced indolent lymphoma using Cyclophosphamide, vinCRIStine and predniSONE - Protocol (01 Jun 2014)
- Preprinted order (01 Mar 2013)
LYCVPPABO: Treatment of Hodgkin's Disease with Cyclophosphamide, vinBLAStine, Procarbazine and predniSONE - Protocol (01 Jun 2014)
- Preprinted order (01 Jun 2014)
LYCVPR: Treatment of Advanced Indolent Lymphoma using Cyclophosphamide, vinCRIStine, predniSONE and riTUXimab (CVP-R) - Protocol (01 Jun 2014)
- Preprinted order (01 Sep 2013)
- Patient Handout (01 Feb 2006)
LYCYCLO: Therapy of Lymphoma, Hodgkin's Disease, Chronic Lymphocytic Leukemia or Multiple Myeloma Using Cyclophosphamide - Protocol (01 Jun 2014)
- Preprinted order (27 Jun 2011)
LYFCR: Treatment of Chronic Lymphocytic Leukemia (CLL) or Prolymphocytic Leukemia with Fludarabine, Cyclophosphamide and riTUXimab Protocol (01 Jul 2014)
Preprinted order (01 Jul 2014)
LYFLU: Treatment of Low-Grade Lymphoma or Chronic Lymphocytic Leukemia with Fludarabine - Protocol (01 Jun 2014)
- Preprinted order (27 Jun 2011)
LYFLUDR: Treatment of Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia and Relapsed Indolent Lymphoma with Fludarabine and riTUXimab - Protocol (01 Jun 2014)
- Preprinted order (01 Apr 2014)
LYGDP: Treatment of Lymphoma with Gemcitabine, Dexamethasone and CISplatin (GDP) - Protocol (01 Jun 2014)
- Preprinted order (01 Jun 2014)
Patient Handout (01 Feb 2013)
LYGDPR: Treatment of Lymphoma with Gemcitabine, Dexamethasone and CISplatin (GDP) with riTUXimab Protocol (01 Jun 2014)
Preprinted order (01 Jun 2014)
Patient Handout (01 Jan 2013)
LYHDMRP: Treatment of Primary Intracerebral Lymphoma with High Dose Methotrexate and riTUXimab - Protocol (01 Jun 2014)
LYHDMTXP: Treatment of Primary Intracerebral Lymphoma with High Dose Methotrexate - Protocol (01 Jun 2014)
LYHDMTXR: Treatment of Leptomeningeal Lymphoma or Recurrent Intracerebral Lymphoma with High Dose Methotrexate - Protocol (01 Jun 2014)
LYIT: Treatment of Lymphoma using Intrathecal Methotrexate and Cytarabine - Protocol (01 Jun 2014)
- Preprinted order (01 Sep 2009)
LYIVACR: Treatment of Burkitt’s Lymphoma and Leukemia (ALL-L3) with Ifosfamide, Mesna, Etoposide, Cytarabine (IVAC) and riTUXimab - Protocol (01 Jun 2014)
- Preprinted order (01 Sep 2013)
ULYMFBEX: Treatment for refractory cutaneous T-cell lymphoma using Bexarotene (Note: approval from the Health Canada Special Access Programme required) - Protocol (01 May 2009)
- Preprinted order (01 Dec 2009)
ULYMFECP: Treatment of Cutaneous T-cell Lymphoma (Sézary syndrome) with Extracorporeal Photopheresis - Protocol (01 Jun 2014)
LYPALL: Lymphoma Palliative Chemotherapy - Protocol (01 Jun 2014)
ULYRICE: Treatment of Advanced Stage Large B-Cell Non-Hodgkin’s Lymphoma with Ifosfamide, CARBOplatin, Etoposide and riTUXimab - Protocol (01 Jun 2014)
- Preprinted order (01 May 2014)
LYRITUX: Treatment of Lymphoma with single agent riTUXimab - Protocol (01 Jun 2014)
- Preprinted order (01 Aug 2013)
ULYRMTN: Maintenance riTUXimab for Indolent Lymphoma - Protocol (01 Jun 2014)
Preprinted order (01 Mar 2013)
UMYBORPRE: Treatment of Multiple Myeloma Using Bortezomib, Dexamethasone with or without Cyclophosphamide as Induction Pre-Stem Cell Transplant Protocol (01 Jun 2014)
Preprinted order
(01 Nov 2012)
UMYBORREL: Treatment of Relapsed Multiple Myeloma Using Bortezomib, Dexamethasone with or without Cyclophosphamide Protocol (01 Jun 2014)
Preprinted order (01 Nov 2012)
UMYCTD: Treatment of Systemic Light-chain (AL) Amyloidosis and Multiple Myeloma Using Cyclophosphamide, Thalidomide and Dexamethasone Protocol (01 Jun 2014)

MYHDC: Single dose cyclophosphamide priming therapy for multiple myeloma prior to autologous stem cell transplant see Leukemia/BMT page
UMYLENDEX: Therapy of Multiple Myeloma Using Lenalidomide with Dexamethasone Protocol (01 May 2014)
Preprinted order (01 May 2014)
Patient Handout (01 Jan 2011)
MYMP: Treatment of Multiple Myeloma Using Melphalan and predniSONE - Protocol (01 Jun 2014)
- Preprinted order (01 May 2009)
UMYMPBOR: Treatment of Multiple Myeloma using Melphalan, Prednisone and Weekly Bortezomib with the Option of Substituting Cyclophosphamide for Melphalan Protocol (01 Jun 2014)
Preprinted order (01 Jul 2012)
UMYMPT: Treatment of Multiple Myeloma Using Melphalan, Prednisone and Thalidomide Protocol (01 Jun 2014)
Preprinted order (01 May 2011)
MYPAM: Treatment of Multiple Myeloma with Pamidronate - Protocol (01 Dec 2011)
- Preprinted order (01 April 2011)
UMYTHALID: Therapy of Multiple Myeloma Using Thalidomide - Protocol (01 Jun 2014)
- Preprinted order (04 Jul 2011)